Shinsuke Araki

Shinsuke Araki

Auto-generated profile, based on publicly available information

Shinsuke Araki

Takeda Pharmaceutical Company

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SAShinsuke Araki
Shinsuke Araki
RDRyo Dairiki
Ryo Dairiki
YNYusuke Nakayama
Yusuke Nakayama
AMAiko Murai
Aiko Murai
RMRisa Miyashita
Risa Miyashita
ONOsamu Nakanishi
Osamu Nakanishi
Accumulating evidence has demonstrated the importance of alternative splicing in various physiological processes, including the development of different diseases. CDC-like kinases (CLKs) and serine-arginine protein kinases (SRPKs) are components of the splicing machinery that are crucial for exon selection. The discovery of small molecule inhibitors against these kinases is of significant value, not only to delineate the molecular mechanisms of splicing, but also to identify potential therapeutic opportunities. Here we describe a series of small molecules that inhibit CLKs and SRPKs and thereby modulate pre-mRNA splicing. Treatment with these small molecules (Cpd-1, Cpd-2, or Cpd-3) significantly reduced the levels of endogenous phosphorylated SR proteins and caused enlargement of nuclear speckles in MDA-MB-468 cells. Additionally, the compounds resulted in splicing alterations of RPS6KB1 (S6K), and subsequent depletion of S6K protein. Interestingly, the activity of compounds selective for CLKs was well correlated with the activity for modulating S6K splicing as well as growth inhibition of cancer cells. A comprehensive mRNA sequencing approach revealed that the inhibitors induced splicing alterations and protein depletion for multiple genes, including those involved in growth and survival pathways such as S6K, EGFR, EIF3D, and PARP. Fluorescence pulse-chase labeling analyses demonstrated that isoforms with premature termination codons generated after treatment with the CLK inhibitors were degraded much faster than canonical mRNAs. Taken together, these results suggest that CLK inhibitors exhibit growth suppression and apoptosis induction through splicing alterations in genes involved in growth and survival. These small molecule inhibitors may be valuable tools for elucidating the molecular machinery of splicing and for the potential development of a novel class of antitumor agents.

23 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
TFTyler Funnell
Tyler Funnell
STShinya Tasaki
Shinya Tasaki
AOArusha Oloumi
Arusha Oloumi
SAShinsuke Araki
Shinsuke Araki
EKEsther Kong
Esther Kong
SASamuel Aparicio
Samuel Aparicio
CDC-like kinase phosphorylation of serine/arginine-rich proteins is central to RNA splicing reactions. Yet, the genomic network of CDC-like kinase-dependent RNA processing events remains poorly defined. Here, we explore the connectivity of genomic CDC-like kinase splicing functions by applying graduated, short-exposure, pharmacological CDC-like kinase inhibition using a novel small molecule (T3) with very high potency, selectivity, and cell-based stability. Using RNA-Seq, we define CDC-like kinase-responsive alternative splicing events, the large majority of which monotonically increase or decrease with increasing CDC-like kinase inhibition. We show that distinct RNA-binding motifs are associated with T3 response in skipped exons. Unexpectedly, we observe dose-dependent conjoined gene transcription, which is associated with motif enrichment in the last and second exons of upstream and downstream partners, respectively. siRNA knockdown of CLK2-associated genes significantly increases conjoined gene formation. Collectively, our results reveal an unexpected role for CDC-like kinase in conjoined gene formation, via regulation of 3′-end processing and associated splicing factors.

1 January 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
DNDaisuke Nakata
Daisuke Nakata
SNShoichi Nakao
Shoichi Nakao
KNKazuhide Nakayama
Kazuhide Nakayama
SAShinsuke Araki
Shinsuke Araki
YNYusuke Nakayama
Yusuke Nakayama
ANAtsushi Nakanishi
Atsushi Nakanishi

2 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRyushin Mizuta
Ryushin Mizuta
SAShinsuke Araki
Shinsuke Araki
MFMakoto Furukawa
Makoto Furukawa
YFYuki Furukawa
Yuki Furukawa
SESyota Ebara
Syota Ebara
DKDaisuke Kitamura
Daisuke Kitamura
Apoptosis and necrosis, two major forms of cell death, can be distinguished morphologically and biochemically. Internucleosomal DNA fragmentation (INDF) is a biochemical hallmark of apoptosis, and caspase-activated DNase (CAD), also known as DNA fragmentation factor 40 kDa (DFF40), is one of the major effector endonucleases. DNase γ, a Mg2+/Ca2+-dependent endonuclease, is also known to generate INDF but its role among other apoptosis-associated endonucleases in cell death is unclear. Here we show that (i) INDF occurs even during necrosis in cell lines, primary cells, and in tissues of mice in vivo, and (ii) DNase γ, but not CAD, is the effector endonuclease for INDF in cells undergoing necrosis. These results document a previously unappreciated role for INDF in necrosis and define its molecular basis.

1 August 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MIMasahiro Ito
Masahiro Ito
TTToshio Tanaka
Toshio Tanaka
ATAkinori Toita
Akinori Toita
NUNoriko Uchiyama
Noriko Uchiyama
HKHironori Kokubo
Hironori Kokubo
YIYasuhiro Imaeda
Yasuhiro Imaeda

3 May 2019 in Communications Biology
Verified
Journal Article
Open access
PDF file
AMAlborz Mazloomian
Alborz Mazloomian
SAShinsuke Araki
Shinsuke Araki
MOMomoko Ohori
Momoko Ohori
AEAmal Mohammad EL-Naggar
Amal Mohammad EL-Naggar
DYDamian Yap
Damian Yap
SASamuel Aparicio
Samuel Aparicio
The RNA helicase EIF4A3 regulates the exon junction complex and nonsense-mediated mRNA decay functions in RNA transcript processing. However, a transcriptome-wide network definition of these functions has been lacking, in part due to the lack of suitable pharmacological inhibitors. Here we employ short-duration graded EIF4A3 inhibition using small molecule allosteric inhibitors to define the transcriptome-wide dependencies of EIF4A3. We thus define conserved cellular functions, such as cell cycle control, that are EIF4A3 dependent. We show that EIF4A3-dependent splicing reactions have a distinct genome-wide pattern of associated RNA-binding protein motifs. We also uncover an unanticipated role of EIF4A3 in the biology of RNA stress granules, which sequester and silence the translation of most mRNAs under stress conditions and are implicated in cell survival and tumour progression. We show that stress granule induction and maintenance is suppressed on the inhibition of EIF4A3, in part through EIF4A3-associated regulation of G3BP1 and TIA1 scaffold protein expression.